IRTCiRhythm Technologies, Inc.

$4B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$51M-3.0% YoY

Gross Profit

$35M69.6% margin

Operating Income

-$20M-39.6% margin

Net Income

-$20M-40.2% margin

EPS (Diluted)

$-0.75

QoQ Revenue Growth

-19.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$12M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$276M

Total Liabilities

$158M

Stockholders' Equity

$118M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$52M	-3.0%
Gross Profit	$35M	$39M	-10.2%
Operating Income	-$20M	-$11M	-90.8%
Net Income	-$20M	-$11M	-90.6%

Revenue Segments

Commercial Payors

$27M52%

Centers For Medicare And Medicaid

$14M27%

Healthcare Institutions

$8M15%

Non-Contracted Third-Party Payors

$3M6%

IRTC Q2 2020 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena